Analyst Research

Report Title Price
Provider: Wright Reports
Provider: Reuters Investment Profile
Provider: GlobalData
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

ChemoMetec A/S maintains FY 2013/2014 financial guidance

Thursday, 15 May 2014 02:30am EDT 

ChemoMetec A/S:Says it has maintained its expectations for FY 2013/2014 revenue of between 43 mln Danish crowns and 45 mln crowns and FY 2013/2014 operating profit (EBITDA) in a range of between 6 mln crowns and 8 mln crowns. 

Company Quote

0.15 +2.59%
19 Dec 2014